Skip to content

ResMed

US · RMD #644 by market cap Listed 1970
235.63 -1.25 -0.53%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Quant vs Street three independent views, side by side

StockVane factor grade
A
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Deteriorating
1 4
■ Upgrades■ Downgrades
  • 1 upgrade vs 4 downgrades among tracked analyst rating changes.
  • The single most recent change was actually an upgrade (RBC Capital moved from Hold to Buy on 2026-09-15), though the broader window skews toward downgrades.

Analyst consensus 8 analysts

Buy
Avg price target 274.29 +16.4%
Price target rangecurrent 235.63
Low235.00
Avg274.29
High320.00
Buy 50% Hold 50% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-02 BofA Securities -- Buy 320.00
2026-11-02 Citi -- Hold 270.00
2026-10-30 Mizuho Securities -- Buy 270.00
2026-10-30 Piper Sandler -- Hold 260.00
2026-10-30 KeyBanc -- Buy 277.00
2026-10-30 Needham -- Hold --
2026-10-30 Citi -- Hold 270.00
2026-10-30 RBC Capital -- Buy 288.00
2026-10-13 Mizuho Securities -- Buy 240.00
2026-10-13 BofA Securities -- Buy 320.00
2026-10-02 Stifel -- Hold 235.00
2026-09-25 Stifel -- Hold --
2026-09-15 RBC Capital -- Buy 262.00
2026-09-10 Citi -- Hold 240.00
2026-08-31 KeyBanc -- Buy 267.00
2026-08-19 Rothschild & Co Redburn -- Hold 230.00
2026-08-11 Mizuho Securities -- Buy 235.00
2026-08-07 William Blair -- Buy --
2026-08-07 Piper Sandler -- Hold 225.00
2026-08-07 KeyBanc -- Buy 255.00
2026-08-07 Needham -- Hold --
2026-08-07 RBC Capital -- Hold 244.00
2026-08-04 Needham -- Hold --
2026-07-29 BofA Securities -- Buy 320.00
2026-07-20 William Blair -- Buy --

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-09-15 RBC Capital Hold → Buy 262.00
2026-07-16 RBC Capital Buy → Hold 234.00
2026-07-10 Citi Buy → Hold 235.00
2026-06-17 Morgan Stanley Buy → Hold 230.00
2025-12-16 Baird Buy → Hold 275.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2027/Q1 2026-10-29 After close ±7.24% -9.05% (beat)
2026/Q4 2026-08-06 After close ±7.75% -5.06% (in line)
2026/Q3 2026-04-30 After close ±7.98% -4.11% (in line)
2026/Q2 2026-01-29 After close ±7.12% +0.27% (in line)
2026/Q1 2025-10-30 After close ±10.09% -2.13% (in line)
2025/Q4 2025-07-31 After close ±9.48% +2.67% (in line)
2025/Q3 2025-04-23 After close ±10.51% +10.10% (in line)
2025/Q2 2025-01-30 After close ±9.29% -8.33% (in line)
2025/Q1 2024-10-24 After close ±11.07% +7.12% (in line)
2024/Q4 2024-08-01 After close ±13.29% +4.23% (in line)
2024/Q2 2024-01-24 After close ±8.85% +8.48% (in line)
2024/Q1 2023-10-26 After close ±12.25% -2.94% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:01:25 · For reference only, not investment advice and not tailored to your situation.

ResMed discussion 0 comments

Add a comment